The science supporting the relationship between carbohydrates and dementia is quite exciting, as it paves the way for lifestyle changes that can profoundly affect a person's chances of remaining intact, at least from a brain perspective.
A lot of people don't want to know, but I'd like to know if I have a 10 percent or a 90 percent chance of developing Alzheimer's some day. If I know I'm likely to develop it, I'm certainly going to start looking around right now to find if there is something that I can do to offset it.
Our intention is not to create cloned human beings, but rather to make lifesaving therapies for a wide range of human disease conditions, including diabetes, strokes, cancer, AIDS, and neurodegenerative disorders such as Parkinson's and Alzheimer's disease.
Alzheimer's, Parkinson's, brain and spinal cord disorders, diabetes, cancer, at least 58 diseases could potentially be cured through stem cell research, diseases that touch every family in America and in the world.
As life expectancy extends beyond 80 years in some parts of the world, more people are struggling with brain diseases. For older people, Alzheimer's, Parkinson's, and other conditions become a major impediment to quality of life.
Studies by many labs have already started to identify specific circuits of neurons involved in normal cognitive function like memory and learning, as well as disease processes such as Parkinson's disease, depression, and autism.
People with Parkinson's are not some weird people on the edge of human experience.
Inflammation is the cornerstone of Alzheimer's disease and Parkinson's, multiple sclerosis - all of the neurodegenerative diseases are really predicated on inflammation.
In Wisconsin, We're at the forefront of research that might one day bring cures for diseases like Parkinsons and Alzheimers, and we must seize its great potential.
If we can map the retina, that will help us understand how it functions in vision, as well as devise new ways of repairing its malfunctions. And if we can really figure out the retina, perhaps we will have a shot at figuring out the vastly more complicated brain.
The bottom line is that this author, a practicing neurologist dealing with Alzheimer's disease on a daily basis, believes we need to expand the public awareness that modifiable lifestyle factors have a profound role to play in determining who will or won't get this disease.
I have a particular passion and focus on Alzheimer's and diseases of dementia. There's just so much scientifically that we don't know, and we can know.
We have to make it socially acceptable to talk about having risk of getting dementia. I think that is one of the ground zero struggles we are going to face in the coming decades.
Discussing new techniques for indicating who was likely to suffer from Alzheimer's Disease.
We see chemistry, how the atoms are arranged in the molecules, how the disease changes the arrangement. Perhaps we will find which drug disentangles the aggregates that make a brain senile. Many of us are interested in such things.
Australia is already a world leader in dementia research, treatment and care.
Being on a sitcom stops me from getting Alzheimer's.
Some genetic variants can be informative about one's risk for Parkinson's disease and Alzheimer's disease.
I can't comment on the internal decision-making at other companies, but RVT-101 has the potential to be a very valuable product in the treatment of Alzheimer's, which is a huge unmet medical need.